デフォルト表紙
市場調査レポート
商品コード
1425811

低分子APIの世界市場レポート 2024

Small Molecule API Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
低分子APIの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

低分子APIの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.4%の年間複合成長率(CAGR)で2,751億4,000万米ドルに成長すると予想されます。今後の成長予測は、サプライチェーンの回復力への注力、医薬品製造におけるデジタル化の統合、腫瘍学への投資の増加、グリーンケミストリーの採用、パンデミックによって引き起こされるヘルスケア需要の進化など、さまざまな要因に関連している可能性があります。この予測期間に予想される注目すべき動向には、バイオ医薬品内の相乗効果、個別化医療の進歩、高度な製造技術の導入、APIアウトソーシングと受託製造の注目度の高まりが含まれます。

低分子API市場は、小分子医薬品の需要の高まりにより、成長の準備が整っています。低分子量を特徴とする小分子薬は、病気の診断、治療、予防のための生化学プロセスの調節において重要な役割を果たします。アスピリンやジフェンヒドラミンなど、薬棚にある一般的な薬は、低分子薬のカテゴリーに分類されます。これらの医薬品はさまざまな病気の予防に貢献しており、2021年にはかなりの割合が食品医薬品局(FDA)に承認されました。 国立バイオテクノロジー情報センター(NCBI)によると、2021年にFDAが承認した医薬品の75%は低分子であり、腫瘍学が主要な治療領域となっています。注目すべきは、これらの承認の50%以上が中小企業からのものであり、製品の商業化をサポートする上で受託開発製造組織(CDMO)が重要な役割を果たしていることが浮き彫りになっています。この傾向は、低分子医薬品の需要の拡大に牽引されて、低分子API市場の成長に貢献しています。

低分子API市場の成長は、慢性疾患の有病率の増加によってさらに促進されています。 3か月以上続く慢性疾患には、心血管疾患、糖尿病、がんなどの病気が含まれ、長期にわたる投薬が必要です。低分子APIは、バイオアベイラビリティの最適化、薬物動態の改善、副作用の軽減を備えた医薬品の製剤化において極めて重要な役割を果たし、慢性疾患の長期治療計画の全体的な有効性と患者の受容性を高めます。国立バイオテクノロジー情報センター(NCBI)の報告によると、世界の慢性疾患人口は2050年までに1億4,266万人に達し、2020年の7,152万2,000人から倍増すると予想されています。この慢性疾患の急増は、低分子APIの需要の増大に寄与し、市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の低分子API市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 合成
  • バイオテクノロジー
  • 世界の低分子API市場、メーカー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 社内
  • 外部委託
  • 世界の低分子API市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 心臓病学
  • 腫瘍学
  • 中枢神経系と神経学
  • 整形外科
  • 内分泌学
  • その他の用途

第7章 地域および国の分析

  • 世界の低分子API市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の低分子API市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 低分子API市場の競合情勢
  • 低分子API市場の企業プロファイル
    • Merck &Co. Inc.
    • AbbVie Inc.
    • Bristol-Myers Squibb Company
    • Albemarle Corporation
    • Boehringer Ingelheim International GmbH

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r13042

Small Molecule API Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule api market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule api? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule api market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Synthetic; Biotech
  • 2) By Manufacturer: In-House; Outsourced
  • 3) By Application: Cardiology; Oncology; CNS And Neurology; Orthopedic; Endocrinology; Other Applications
  • Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company; Albemarle Corporation; Boehringer Ingelheim International GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Small molecules API (active pharmaceutical ingredients) are organic compounds characterized by their low molecular weight, typically less than 1 nanometer and comprised of 20-100 atoms. These active ingredients play a pivotal role in various biological and pharmaceutical processes, serving as fundamental components. Small molecules APIs find extensive applications in both pharmaceutical and biological procedures, aiding in the exploration of biological functions and contributing to the development of novel therapeutic agents.

The primary categories of small molecule APIs encompass synthetic and biotech variations. Synthetic small molecule APIs are created within laboratory settings through diverse chemical processes. Manufacturing of these small molecule APIs can occur in-house or through outsourced means, catering to multiple applications such as cardiology, oncology, CNS and neurology, orthopaedics, endocrinology, and various other medical fields.

The small molecule API market research report is one of a series of new reports from The Business Research Company that provides small molecule API market statistics, including small molecule API industry global market size, regional shares, competitors with a small molecule API market share, detailed small molecule API market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule API industry. This small molecule API market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule api market size has grown strongly in recent years. It will grow from $193.44 billion in 2023 to $206.88 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The historical growth in this sector can be attributed to the expansion of generic drug manufacturing, heightened investment in research and development, growing demands from an aging population, advancements in oncology treatments, and the emergence of targeted therapies.

The small molecule api market size is expected to see strong growth in the next few years. It will grow to $275.14 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The projected growth in the upcoming period can be linked to various factors, including a focus on supply chain resilience, the integration of digitalization in pharmaceutical manufacturing, heightened investments in oncology, the adoption of green chemistry, and the evolving healthcare demands driven by the pandemic. Notable trends anticipated in this forecast period encompass the synergy within biopharmaceuticals, the advancement of personalized medicine, the implementation of advanced manufacturing techniques, and the increasing prominence of API outsourcing and contract manufacturing.

The small-molecule API market is poised for growth, driven by the increasing demand for small-molecule drugs. Small-molecule drugs, characterized by low molecular weight, play a crucial role in modulating biochemical processes to diagnose, treat, or prevent diseases. Common medications found in medicine cabinets, such as aspirin and diphenhydramine, fall under the category of small-molecule drugs. These drugs contribute to preventing various diseases, with a significant proportion being accepted by the Food and Drug Administration (FDA) in 2021. According to the National Center for Biotechnology Information (NCBI), 75% of FDA-approved drugs in 2021 were small molecules, with oncology being the dominant therapeutic area. Notably, over 50% of these approvals originated from small and mid-sized companies, underscoring the crucial role of Contract Development and Manufacturing Organizations (CDMOs) in supporting the commercialization of products. This trend contributes to the growth of the small-molecule API market, driven by the expanding demand for small-molecule drugs.

The growth of the small-molecule API market is further propelled by the increasing prevalence of chronic diseases. Chronic diseases, lasting three months or more, include conditions like cardiovascular diseases, diabetes, and cancer, necessitating long-term medication. Small-molecule APIs play a pivotal role in formulating drugs with optimized bioavailability, improved pharmacokinetics, and reduced side effects, enhancing the overall effectiveness and patient acceptability of long-term treatment regimens for chronic conditions. As reported by the National Center for Biotechnology Information (NCBI), the global population with chronic diseases is expected to reach 142.66 million by 2050, doubling from 71.522 million in 2020. This surge in chronic diseases contributes to the growing demand for small-molecule APIs, driving the growth of the market.

A notable trend in the small-molecule API market is the emphasis on strategic partnerships. Many companies in the market are actively engaging in partnerships to strengthen their market positions and advance the development of drugs and therapies. For instance, in March 2023, CatSci Ltd., a UK-based pharmaceutical company, partnered with AGC Pharma Chemicals, a Spain-based pharmaceutical company, to enhance drug development. This collaboration leverages CatSci's non-clinical expertise with AGC's manufacturing capabilities, particularly supporting clinical phase projects. The partnership aims to provide strategic value, expedite drug development timelines, and deliver impactful small-molecule API-based medicines globally. This trend underscores the significance of collaborative efforts in driving innovation and growth within the small-molecule API market.

Major companies in the small molecules API market are actively developing new technologies to address solubility challenges, particularly for oral small molecules. In March 2022, Evonik Industries AG, a leading Germany-based specialty chemicals company, introduced EUDRATEC SoluFlow. This microparticle technology is specifically designed to enhance the solubility of active pharmaceutical ingredients (APIs) in oral drugs. EUDRATEC SoluFlow employs an emulsion-based process to overcome solubility challenges for over 70% of new small molecules. The technology facilitates the development of oral therapeutics in critical medical areas by transforming poorly soluble drugs into easily processed amorphous solid dispersions (ASD). Notably, this innovation reduces post-processing complexity, offering a significant advancement in addressing solubility issues for oral small molecules.

In a strategic move, GHO Capital, a European specialist investor in healthcare companies, made a noteworthy acquisition in March 2022 by securing a majority stake in Sterling Pharma Solutions. This acquisition positions GHO Capital to leverage extensive pharmaceutical expertise in Europe and expand its market presence in the United States. Sterling Pharma Solutions, a US-based manufacturer specializing in active pharmaceutical ingredients (APIs), aligns with GHO Capital's strategic objectives in the healthcare sector. This move underscores the significance of strategic investments and partnerships in driving growth and innovation within the small molecules API market.

Major companies operating in the small molecule api market report are Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Albemarle Corporation, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Cambrex Corporation, Lonza Group AG, Siegfried Holding AG, AstraZeneca, F. Hoffmann-La Roche AG, Nanjing King-friend Biochemical Pharmaceutical Co. Ltd., Albany Molecular Research Inc., Allergan PLC, Atomwise Inc., BASF SE, BenevolentAI Limited, Certara L.P., Exscientia AI Limited, Gilead Sciences Inc., GlaxoSmithKline PLC, HotSpot Therapeutics Inc., Insitro Inc., Johnson Matthey PLC, Novartis AG

North America was the largest region in the small molecule API market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule api market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small molecule api market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecules API market consists of sales of contract and captive small molecules API. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Small Molecule API Market Characteristics

3. Small Molecule API Market Trends And Strategies

4. Small Molecule API Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Small Molecule API Market Size and Growth

  • 5.1. Global Small Molecule API Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Small Molecule API Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Small Molecule API Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Small Molecule API Market Segmentation

  • 6.1. Global Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Synthetic
  • Biotech
  • 6.2. Global Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Outsourced
  • 6.3. Global Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiology
  • Oncology
  • CNS And Neurology
  • Orthopaedic
  • Endocrinology
  • Other Applications

7. Small Molecule API Market Regional And Country Analysis

  • 7.1. Global Small Molecule API Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Small Molecule API Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Small Molecule API Market

  • 8.1. Asia-Pacific Small Molecule API Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Small Molecule API Market

  • 9.1. China Small Molecule API Market Overview
  • 9.2. China Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Small Molecule API Market

  • 10.1. India Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Small Molecule API Market

  • 11.1. Japan Small Molecule API Market Overview
  • 11.2. Japan Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Small Molecule API Market

  • 12.1. Australia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Small Molecule API Market

  • 13.1. Indonesia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Small Molecule API Market

  • 14.1. South Korea Small Molecule API Market Overview
  • 14.2. South Korea Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Small Molecule API Market

  • 15.1. Western Europe Small Molecule API Market Overview
  • 15.2. Western Europe Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Small Molecule API Market

  • 16.1. UK Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Small Molecule API Market

  • 17.1. Germany Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Small Molecule API Market

  • 18.1. France Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Small Molecule API Market

  • 19.1. Italy Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Small Molecule API Market

  • 20.1. Spain Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Small Molecule API Market

  • 21.1. Eastern Europe Small Molecule API Market Overview
  • 21.2. Eastern Europe Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Small Molecule API Market

  • 22.1. Russia Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Small Molecule API Market

  • 23.1. North America Small Molecule API Market Overview
  • 23.2. North America Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Small Molecule API Market

  • 24.1. USA Small Molecule API Market Overview
  • 24.2. USA Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Small Molecule API Market

  • 25.1. Canada Small Molecule API Market Overview
  • 25.2. Canada Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Small Molecule API Market

  • 26.1. South America Small Molecule API Market Overview
  • 26.2. South America Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Small Molecule API Market

  • 27.1. Brazil Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Small Molecule API Market

  • 28.1. Middle East Small Molecule API Market Overview
  • 28.2. Middle East Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Small Molecule API Market

  • 29.1. Africa Small Molecule API Market Overview
  • 29.2. Africa Small Molecule API Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Small Molecule API Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Small Molecule API Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Small Molecule API Market Competitive Landscape And Company Profiles

  • 30.1. Small Molecule API Market Competitive Landscape
  • 30.2. Small Molecule API Market Company Profiles
    • 30.2.1. Merck & Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AbbVie Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bristol-Myers Squibb Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Albemarle Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boehringer Ingelheim International GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Small Molecule API Market Competitive Benchmarking

32. Global Small Molecule API Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Small Molecule API Market

34. Small Molecule API Market Future Outlook and Potential Analysis

  • 34.1 Small Molecule API Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Small Molecule API Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Small Molecule API Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer